Mark A. Clements

Mark A. Clements

Auto-generated profile, based on publicly available information

Mark A. Clements

Division of Pediatric Endocrinology, Children’s Mercy Hospital, University of Missouri-Kansas City 16 , Kansas City, MO

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
DKDavid C. Klonoff
David C. Klonoff
JWJing Wang
Jing Wang
DRDavid Rodbard
David Rodbard
MKMichael A. Kohn
Michael A. Kohn
CLChengdong Li
Chengdong Li
BKBoris Kovatchev
Boris Kovatchev
Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data. Methods: We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low–glucose and low-glucose hypoglycemia; very high–glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation. Results: The analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals. Conclusion: The GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.

10 December 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
RRRavi Kondama Reddy
Ravi Kondama Reddy
RPRubin Pooni
Rubin Pooni
DZDessi Zaharieva
Dessi Zaharieva
BSBrian Senf
Brian Senf
JYJoseph El Youssef
Joseph El Youssef
PJPeter Jacobs
Peter Jacobs
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Wrist-worn activity monitors are often used to monitor heart rate (HR) and energy expenditure (EE) in a variety of settings, including more recently in medical applications. The use of real time physiological signals to inform medical systems including drug delivery systems and decision support systems will depend on the accuracy of the signals being measured including accuracy of HR and EE. Prior studies assessed accuracy of wearables only during steady state aerobic exercise. Objective: The objective of this study was to validate the accuracy of both HR and EE for two common wrist-worn devices during a variety of dynamic activities that represent various physical activities associated with daily living including structured exercise. Methods: We assessed the accuracy of both HR and EE for two common wrist-worn devices (Fitbit Charge 2TM, Garmin vívosmart® HR+) during dynamic activities. Over a two-day period, 20 healthy adults (age: 27.5 ± 6.0 yrs; BMI: 22.5 ± 2.3 kg/m2; 11 females) performed a maximal oxygen uptake test, free-weight resistance circuit, interval training session, and activities of daily living. Validity was assessed using a HR chest strap (Polar®) and portable indirect calorimetry (Cosmed). Accuracy of the commercial wearables versus research-grade standards was determined using Bland-Altman analysis, correlational analysis, and error bias. Results: Fitbit and Garmin were reasonably accurate at measuring HR but with an overall negative bias. There was more error observed during high intensity activities, when there was a lack of repetitive wrist motion, and when the exercise mode indicator was not used. The Garmin estimated HR with a mean relative error (%RE) of -3.3% ± 16.7 while Fitbit estimated HR with a %RE of -4.7% ± 19.6 across all activities. The highest error was observed during high intensity intervals on bike (Fitbit: -11.4% ± 35.7; Garmin: -14.3% ± 20.5) and lowest error during high intensity intervals on treadmill (Fitbit: -1.7% ± 11.5; Garmin: -0.5% ± 9.4). Fitbit and Garmin EE estimates differed significantly with Garmin having less negative bias (Fitbit: -19.3% ± 29.9, Garmin: -1.6% ± 30.6, P<.001) across all activities, with both correlating poorly with indirect calorimetry measures. Conclusions: Two common wrist-worn devices show good HR accuracy, with a small negative bias, and reasonable EE estimates during low to moderate intensity exercise and during a variety of common daily activities and exercise. Accuracy was compromised markedly when the activity indicator was not used on the watch or when activities involving less wrist motion such as cycle ergometry were done.

7 February 2023 in Diabetes Care
Verified
Journal Article
Open access
PDF file
MRMichael C Riddell
Michael C Riddell
ZLZoey Li
Zoey Li
RGRobin L. Gal
Robin L. Gal
PCPeter Calhoun
Peter Calhoun
PJPeter Jacobs
Peter Jacobs
TGT1DEXI Study Group
T1DEXI Study Group
OBJECTIVE: Maintenance of glycemic control during and after exercise remains a major challenge for individuals with type 1 diabetes. Glycemic responses to exercise may differ by exercise type (aerobic, interval, or resistance), and the effect of activity type on glycemic control after exercise remains unclear.RESEARCH DESIGN AND METHODS: The Type 1 Diabetes Exercise Initiative (T1DEXI) was a real-world study of at-home exercise. Adult participants were randomly assigned to complete six structured aerobic, interval, or resistance exercise sessions over 4 weeks. Participants self-reported study and nonstudy exercise, food intake, and insulin dosing (multiple daily injection [MDI] users) using a custom smart phone application and provided pump (pump users), heart rate, and continuous glucose monitoring data.RESULTS: A total of 497 adults with type 1 diabetes (mean age ± SD 37 ± 14 years; mean HbA1c ± SD 6.6 ± 0.8% [49 ± 8.7 mmol/mol]) assigned to structured aerobic (n = 162), interval (n = 165), or resistance (n = 170) exercise were analyzed. The mean (± SD) change in glucose during assigned exercise was −18 ± 39, −14 ± 32, and −9 ± 36 mg/dL for aerobic, interval, and resistance, respectively (P < 0.001), with similar results for closed-loop, standard pump, and MDI users. Time in range 70–180 mg/dL (3.9–10.0 mmol/L) was higher during the 24 h after study exercise when compared with days without exercise (mean ± SD 76 ± 20% vs. 70 ± 23%; P < 0.001).CONCLUSIONS: Adults with type 1 diabetes experienced the largest drop in glucose level with aerobic exercise, followed by interval and resistance exercise, regardless of insulin delivery modality. Even in adults with well-controlled type 1 diabetes, days with structured exercise sessions contributed to clinically meaningful improvement in glucose time in range but may have slightly increased time below range.

3 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MRMichael R. Rickels
Michael R. Rickels
CECarmella Evans-Molina
Carmella Evans-Molina
HBHenry T. Bahnson
Henry T. Bahnson
AYAlyssa Ylescupidez
Alyssa Ylescupidez
KNKristen J. Nadeau
Kristen J. Nadeau
CGCarla J. Greenbaum
Carla J. Greenbaum
BACKGROUND. Residual C-peptide is detected in many people for years following the diagnosis of type 1 diabetes; however, the physiologic significance of low levels of detectable C-peptide is not known. METHODS. We studied 63 adults with type 1 diabetes classified by peak mixed-meal tolerance test (MMTT) C-peptide as negative (0.200–0.400; n = 15), or high (>0.400; n = 17). We compared the groups’ glycemia from continuous glucose monitoring (CGM), β cell secretory responses from a glucose-potentiated arginine (GPA) test, insulin sensitivity from a hyperinsulinemic-euglycemic (EU) clamp, and glucose counterregulatory responses from a subsequent hypoglycemic (HYPO) clamp. RESULTS. Low and intermediate MMTT C-peptide groups did not exhibit β cell secretory responses to hyperglycemia, whereas the high C-peptide group showed increases in both C-peptide and proinsulin (P ≤ 0.01). All groups with detectable MMTT C-peptide demonstrated acute C-peptide and proinsulin responses to arginine that were positively correlated with peak MMTT C-peptide (P < 0.0001 for both analytes). During the EU-HYPO clamp, C-peptide levels were proportionately suppressed in the low, intermediate, and high C-peptide compared with the negative group (P ≤ 0.0001), whereas glucagon increased from EU to HYPO only in the high C-peptide group compared with negative (P = 0.01). CGM demonstrated lower mean glucose and more time in range for the high C-peptide group. CONCLUSION. These results indicate that in adults with type 1 diabetes, β cell responsiveness to hyperglycemia and α cell responsiveness to hypoglycemia are observed only at high levels of residual C-peptide that likely contribute to glycemic control. FUNDING. Funding for this work was provided by the Leona M. and Harry B. Helmsley Charitable Trust, the National Center for Advancing Translational Sciences, and the National Institute of Diabetes and Digestive and Kidney Diseases.

31 October 2019 in Diabetes Care
Verified
Journal Article
Open access
PDF file
KMKellee M. Miller
Kellee M. Miller
JHJulia Hermann
Julia Hermann
NFNicole Foster
Nicole Foster
SHSabine E. Hofer
Sabine E. Hofer
MRMichael R. Rickels
Michael R. Rickels
RHReinhard W. Holl
Reinhard W. Holl

1 April 2020 in Clinical Diabetes
Verified
Journal Article
Closed access
PDF file
GAGuy Todd Alonso
Guy Todd Alonso
SCSarah Corathers
Sarah Corathers
ASAvni Shah
Avni Shah
MCMark Clements
Mark Clements
MKManmohan Kamboj
Manmohan Kamboj
JLJoyce Lee
Joyce Lee
The T1D Exchange established a learning platform by evaluating the current state of care and engaging 10 diabetes clinics in collaborative quality improvement (QI) activities. Participating clinics are sharing data and best practices to improve care delivery for people with type 1 diabetes. This article describes the design and initial implementation of this platform, known as the T1D Exchange Quality Improvement Collaborative. This effort has laid a foundation for learning from variation in type 1 diabetes care delivery via QI methodology and has demonstrated success in improving processes through iterative testing cycles and transparent sharing of data.